Enter your terms above and click the 'Search' button.

Showing articles 0 to 7 of 7 Filter Applied: alemtuzumab (Click to remove) Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis Neruol 90:852-854, Ferraro, D.,et al, 2018 Myasthenia Gravis Following Alemtuzumab Therapy for Multiple Sclerosis Neurol 91:622-624, Midaglia, L.,et al, 2018 Alemtuzumab CARE-MS I 5-year follow-up Neurol 89:1107-1116, Havrdova, E.,et al, 2017 Alemtuzumab CARE-MS II 5-year follow-up Neurol 89:1117-1126, Coles, A.J.,et al, 2017 Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS Neurol 87:1464-1472, Arnold, D.L.,et al, 2016 Alemtuzumab for Multiples Sclerosis: Who and When to treat? Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012 Monoclonal Antibody Therapies and Neurologic Disorders Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008 Showing articles 0 to 7 of 7